Loading...
A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomas
In order to achieve higher dosages than previously used in clinical trials, we conducted a phase I trial to determine the maximum tolerated dose (MTD) for the combination of erlotinib and sirolimus for the treatments of recurrent malignant gliomas. Patients with pathologically proven World Health Or...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer US
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3472078/ https://ncbi.nlm.nih.gov/pubmed/22918789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-012-0960-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|